Skip to main content
. 2022 Aug 8;12(13):5931–5948. doi: 10.7150/thno.74281

Figure 5.

Figure 5

Predictive value of the TIIClnc signature in immunotherapy response. A. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the IMvigor dataset. B. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the IMvigor dataset. C. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE179351 dataset. D. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the Braun dataset. E. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the Braun dataset. F. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE103668 dataset. G. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE165252 dataset. H. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the Allen dataset. I. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the Allen dataset. J. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the GSE78220 dataset. K. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE78220 dataset. L. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the Nathanson dataset. M. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the Nathanson dataset. N. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE35640 dataset. O. Box plot displaying the TIIClnc signature score in patients with different immunotherapy responses in the GSE91061 dataset. P. Contingency table between immunotherapy responses and TIIClnc signature score groups based on TIDE algorithm in the Xiangya in-house dataset. Q. Contingency table between immunotherapy responses (anti-PD-1 and anti-CTLA-4) and TIIClnc signature score groups based on submap analysis in the Xiangya in-house dataset. R. Kaplan-Meier survival curve of OS between patients with a high score of TIIClnc signature and a low score of TIIClnc signature in the PRJNA482620 dataset.